VYNE Therapeutics Inc. (NASDAQ:VYNE) is held by 44 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Shay Capital LLC | 31 Dec, 2025 | 1,624,349 | 1,131,772 | 229.77% | $942,285.00 |
| Anson Funds Management LP | 31 Dec, 2025 | 1,274,386 | 1,274,386 | 0.00% | $739,271.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 1,000,000 | 1,000,000 | 0.00% | $580,100.00 |
| T3 Companies, LLC | 31 Dec, 2025 | 945,000 | 945,000 | 0.00% | $548,195.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 638,492 | 192,078 | 43.03% | $370.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 507,582 | 507,582 | 0.00% | $294,448.00 |
| KVP Capital Advisors, LP | 31 Dec, 2025 | 500,551 | 500,551 | 0.00% | $290,370.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 314,545 | 124,162 | 65.22% | $182,436.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 264,912 | -25,088 | -8.65% | $153,675.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 225,152 | 88,030 | 64.20% | $130,614.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 220,000 | -788 | -0.36% | $127,622.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 163,100 | 106,500 | 188.16% | $94,614.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 100,341 | 42,578 | 73.71% | $58,207.00 |
| Rangeley Capital, LLC | 31 Dec, 2025 | 100,000 | 50,000 | 100.00% | $58,010.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 81,371 | -25,088 | -23.57% | $47,203.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 79,040 | 79,040 | 0.00% | $45,851.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 72,356 | -74,764 | -50.82% | $41,974.00 |
| UBS Group AG | 31 Dec, 2025 | 62,761 | 57,189 | 1,026.36% | $36,401.00 |
| GSA CAPITAL PARTNERS LLP | 31 Dec, 2025 | 53,961 | 18,040 | 50.22% | $31.00 |
| STALEY CAPITAL ADVISERS INC | 31 Dec, 2025 | 51,472 | 0 | 0.00% | $29,859.00 |